VWR Corporation Prices Public Offering by Selling Stockholder
Radnor, PA, – VWR Corporation (NASDAQ: VWR)announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock by selling stockholder Varietal Distribution Holdings, LLC at a price to the public of $26.00 per share. The offering is expected to close on April 5, 2016. VWR will not receive any proceeds from this offering. In connection with the offering, the selling stockholder has granted the underwriters a 30-day option to purchase up to 1,200,000 additional shares.
Goldman, Sachs & Co. and Barclays are acting as joint book-running managers of the offering.
An automatic shelf registration statement relating to these securities was filed with the Securities and Exchange Commission (the “Commission”) on November 10, 2015 and became effective upon filing. The offering is being made only by means of a prospectus and prospectus supplement. You may obtain these documents for free by visiting EDGAR on the Commission’s website at www.sec.gov. Alternatively, the prospectus and prospectus supplement may be obtained from: Goldman, Sachs & Co., Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing prospectus-ny@ny.email.gs.com; or Barclays, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by calling 888-603-5847, or by emailing barclaysprospectus@broadridge.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About VWR Corporation
VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is a leading, global, independent provider of products, services and solutions to laboratory and production facilities. With sales in excess of $4.3 billion in 2015, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers’ productivity from research to production. VWR’s differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of approximately 9,300 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.

